Rochester, MNNCT06075524Now EnrollingIRB Ready

Clinical Stage III Cutaneous Melanoma AJCC v8 Clinical Trial in Rochester, MN

Access cutting-edge clinical stage iii cutaneous melanoma ajcc v8 treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.

Sponsored by Mayo Clinic

Quick Self-Assessment

See if you qualify for this Rochester location

Preparing your pre-screening questions…

Expert Care in Rochester

Access clinical stage iii cutaneous melanoma ajcc v8 specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related clinical stage iii cutaneous melanoma ajcc v8 treatment provided free

Apply for This Rochester Location

Check if you qualify for this clinical stage iii cutaneous melanoma ajcc v8 clinical trial in Rochester, MN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Rochester

    Convenient for MN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Rochester site if eligible
  4. 4Begin participation

About This Clinical Stage III Cutaneous Melanoma AJCC v8 Study in Rochester

This study explores the role of T cells in monitoring disease status and response during anti-PD-1/PD-L1 treatment in patients with melanoma, lung and other cancer types. Measuring levels of specific targets such as Bim and soluble PD-L1 during therapy may help track treatment resistance and clinical outcomes. This information may also help researchers determine why some people with melanoma, lung and other cancer types respond to PD-1/PD-L1 treatment and others do not.

Sponsor: Mayo Clinic

Who Can Participate

Inclusion Criteria

Are 18 years of age or older
Have histologic evidence of locally or regionally advanced or stage IV malignancy
Are considered appropriate for starting therapy with anti-PD-1/anti-PD-L1 monoclonal antibody by their treating physician (prior therapy with immune checkpoint inhibitor (ICI) is allowed)
Have an understanding of the protocol and its requirements, risks, and discomforts
Are willing to undergo peripheral blood collection at the time points mentioned in the protocol
Are able and willing to sign an informed consent

Exclusion Criteria

Inability on the part of the patient to understand the informed consent or be compliant with the protocol
Patients receiving any concurrent anti-cancer therapy or investigational agents (with the exception of an anti-PD-1/anti-PD-L1 agent as mentioned above)
Patients who are pregnant, nursing, or are of childbearing potential and are unwilling to employ adequate contraception

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Rochester?

Yes, this clinical trial (NCT06075524) has an active research site in Rochester, MN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Clinical Stage III Cutaneous Melanoma AJCC v8 Treatment Options in Rochester, MN

If you're searching for clinical stage iii cutaneous melanoma ajcc v8 treatment options in Rochester, MN, this clinical trial (NCT06075524) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced clinical stage iii cutaneous melanoma ajcc v8 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all clinical stage iii cutaneous melanoma ajcc v8 clinical trials near you to find additional studies recruiting in your area.

More Melanoma Trials in Rochester, MN

See all melanoma clinical trials recruiting in Rochester — not just this study.

Browse Melanoma Trials in Rochester

Ready to Join in Rochester?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Rochester, MN